You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pretreated Ovarian Carcinoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

Not yet recruiting
  • Serous Ovarian Cancer
  • Advanced Ovarian Cancer
  • (no location specified)
Sep 20, 2023

Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)

Not yet recruiting
  • Ovarian Carcinoma
  • Sacituzumab govitecan
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 31, 2023

Metabolic Biomarkers and Their Prognostic Relationship in

Not yet recruiting
  • Ovarian Cancer
  • No intervention
  • (no location specified)
Aug 24, 2023

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)

Recruiting
  • Mucinous Ovarian Cancer
  • +2 more
  • Bevacizumab + modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 25, 2022

Improved Diagnosis of Ovarian Cancer

Recruiting
  • Ovarian Neoplasms
  • +6 more
    • Aarhus, Denmark
      Department of Gynaecology and Obstetrics, Aarhus University Hosp
    May 1, 2023

    Total Management of Ovarian Cancer

    Not yet recruiting
    • Tumor of Female Reproductive System
    • Ovarian Cancer
    • No intervention
    • (no location specified)
    Aug 30, 2023

    Early Screening of Epithelial Ovarian Cancer

    Not yet recruiting
    • Ovarian Cancer
    • +2 more
    • Fragmentomics
    • (no location specified)
    Jun 26, 2023

    Participation Patterns Among Recurrent Ovarian Cancer Patients

    Not yet recruiting
    • Recurrent Ovarian Cancer
      • San Francisco, California
        Power Life Sciences
      Sep 30, 2023

      Ovarian Cancer Trial in Roma (Blood sample)

      Recruiting
      • Ovarian Cancer
      • Blood sample
      • Roma, Italy
        Policlinico Universitario Agostino Gemelli
      Oct 10, 2023

      Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

      Not yet recruiting
      • Platinum-Resistant Fallopian Tube Carcinoma
      • +5 more
      • Biopsy
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Jan 3, 2023

      Relapsed Ovarian Cancer Trial (Fluzoparib+Apatinib, Fluzoparib Monotherapy)

      Not yet recruiting
      • Relapsed Ovarian Cancer
      • (no location specified)
      Jul 27, 2022

      Ovarian Epithelial Carcinoma, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Sacramento (AHCC, Chemotherapy, Placebo)

      Not yet recruiting
      • Ovarian Epithelial Carcinoma
      • +2 more
      • Sacramento, California
        University of California Davis Comprehensive Cancer Center
      Feb 27, 2023

      Ex Vivo Drug Response and Clinical Outcome in Ovarian Cancer

      Recruiting
      • Epithelial Ovarian Cancer
      • Biological sample collection
      • Linz, Upper Austria, Austria
      • +2 more
      Sep 28, 2023

      Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

      Not yet recruiting
      • Ovarian Cancer
      • Olaparib tablet
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Nov 1, 2023

      Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

      Recruiting
      • Platinum-resistant Ovarian Cancer
      • +6 more
      • olvimulogene nanivacirepvec
      • +3 more
      • Orlando, Florida
        AdventHealth Cancer Institute
      Sep 1, 2022

      Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

      Terminated
      • Ovarian Cancer
      • +21 more
      • Exercise Counseling
      • +5 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 6, 2022

      Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

      Recruiting
      • Advanced Ovarian Carcinoma
      • +7 more
      • Bydgoszcz, Kujawsko-pomorskie, Poland
      • +2 more
      Mar 7, 2023

      Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)

      Not yet recruiting
      • Ovarian Cancer Stage III
      • Ovarian Cancer Stage IV
      • Artificial Intelligence
      • (no location specified)
      Aug 24, 2023

      Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)

      Active, not recruiting
      • Ovarian Cancer
      • Platinum-resistant Ovarian Cancer
      • Minsk, Belarus
        Minsk City Clinical Oncology Center
      Jul 27, 2023

      ctDNA Predicts Recurrence of Advanced Ovarian Cancer After

      Recruiting
      • Ovarian Cancer Stage IV
      • Ovarian Cancer Stage III
        • Guangzhou, Guangdong, China
          Sun Yat-Sen Memorial Hospital
        Aug 30, 2023

        Ovarian Cancer Trial in Maywood (Minoxidil)

        Recruiting
        • Ovarian Cancer
        • Maywood, Illinois
          Loyola University Medical Center
        Jun 23, 2022

        Ovarian Cancer Trial in Rome (Tumor and blood sample)

        Recruiting
        • Ovarian Cancer
        • Tumor and blood sample
        • Rome, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Jul 18, 2023

        Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

        Not yet recruiting
        • Epithelial Ovarian Cancer
        • Ovarian Carcinoma
        • XP-DC vaccinations
        • Nijmegen, Gelderland, Netherlands
          Radboud University Medical Center
        Mar 6, 2023

        Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)

        Active, not recruiting
        • Small Cell Carcinoma, Hypercalcaemic Type
        • Ovarian Cancer
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jan 8, 2023

        Advanced Ovarian Cancer Trial in Guangzhou (Plasmodium immunotherapy)

        Not yet recruiting
        • Advanced Ovarian Cancer
        • Plasmodium immunotherapy
        • Guangzhou, Guangdong, China
          The Third Affiliated Hospital of Southern Medical University
        Jul 5, 2023